{"id":12823,"date":"2022-11-01T10:50:14","date_gmt":"2022-11-01T09:50:14","guid":{"rendered":"https:\/\/iph-multisite.berta-bewegt.ch\/?p=12823"},"modified":"2026-03-03T10:49:36","modified_gmt":"2026-03-03T09:49:36","slug":"medienmitteilung-animal-welfare-report-2022-tierversuche-sind-immer-noch-unerlaesslich-fuer-die-erforschung-neuer-behandlungsansaetze","status":"publish","type":"post","link":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-animal-welfare-report-2022-tierversuche-sind-immer-noch-unerlaesslich-fuer-die-erforschung-neuer-behandlungsansaetze\/","title":{"rendered":"Communiqu\u00e9 de presse: Animal Welfare Report 2022: l\u2019exp\u00e9rimentation animale reste indispensable pour la recherche de nouvelles approches de traitement"},"content":{"rendered":"\n<p class=\"is-style-paragraph-lead-text\">La population suisse a compris l\u2019importance de la recherche impliquant des animaux pour le d\u00e9veloppement de nouveaux m\u00e9dicaments et vaccins et, en f\u00e9vrier 2022, par 79% de \u00abnon\u00bb, elle a clairement rejet\u00e9 dans les urnes l\u2019initiative d\u2019interdiction de l\u2019exp\u00e9rimentation animale et humaine. C\u2019est important car les exp\u00e9riences sur animaux restent indispensables pour \u00e9tudier des maladies omnipr\u00e9sentes comme diverses formes de cancer, la scl\u00e9rose en plaques ou la maladie d\u2019Alzheimer, et d\u00e9velopper de nouvelles approches de traitement. L\u2019Animal Welfare Report publi\u00e9 cette ann\u00e9e par Interpharma illustre ce lien de mani\u00e8re impressionnante par les prix Nobel attribu\u00e9s depuis 120&nbsp;ans.<\/p>\n\n\n\n<p>Cette ann\u00e9e, l\u2019Animal Welfare Report d\u2019Interpharma montre \u00e0 l\u2019aide de trois grands th\u00e8mes o\u00f9 en est l\u2019exp\u00e9rimentation animale dans l\u2019industrie pharmaceutique pratiquant la recherche:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Le premier grand th\u00e8me r\u00e9fute l\u2019affirmation fr\u00e9quente selon laquelle les r\u00e9sultats de l\u2019exp\u00e9rimentation animale ne peuvent pas \u00eatre extrapol\u00e9s \u00e0 l\u2019\u00eatre humain. Les prix Nobel attribu\u00e9s depuis 120&nbsp;ans montrent que de nombreux progr\u00e8s m\u00e9dicaux majeurs n\u2019ont \u00e9t\u00e9 possibles que gr\u00e2ce \u00e0 des exp\u00e9riences men\u00e9es sur des animaux.<\/li><li>Le deuxi\u00e8me grand th\u00e8me pr\u00e9sente la manipulation responsable des animaux par les chercheuses et chercheurs. L\u2019article \u00abDe l\u2019\u00e9levage au laboratoire\u00bb montre sous un angle pratique et clair ce que font les entreprises pharmaceutiques pratiquant la recherche pour am\u00e9liorer le bien-\u00eatre animal, y compris dans leur coop\u00e9ration avec les \u00e9leveurs d\u2019animaux d\u2019exp\u00e9riences et les entreprises de transport.<\/li><li>Dans une interview, Daniel Breustedt, chef d\u2019\u00e9quipe dans la division Scientific Operations\/Comparative Medicine du NIBR, informe des raisons pour lesquelles il n\u2019est pas possible d\u2019\u00e9viter compl\u00e8tement l\u2019exp\u00e9rimentation animale et des possibilit\u00e9s de r\u00e9duction qui existent.<\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-des-incitations-plutot-que-des-interdictions-les-principes-des-3r\"><strong>Des incitations plut\u00f4t que des interdictions: les principes des 3R <\/strong><strong><\/strong><\/h2>\n\n\n\n<p>Malgr\u00e9 la profession de foi pour la recherche m\u00e9dicale, il faut continuer \u00e0 favoriser le bien-\u00eatre animal. Les exp\u00e9riences sur animaux sont essentielles pour la recherche de traitements ou de vaccins qui sauvent des vies. S\u2019agissant des contr\u00f4les de qualit\u00e9 r\u00e8glementaires, on ne peut renoncer aux exp\u00e9riences sur animaux que s\u2019il existe des alternatives valid\u00e9es, reconnues \u00e0 l\u2019\u00e9chelon international. L\u2019industrie veut continuer \u00e0 r\u00e9duire le nombre d\u2019exp\u00e9riences sur animaux et \u00e0 en perfectionner les normes d\u00e9j\u00e0 \u00e9lev\u00e9es. Pour cela, elle s\u2019oriente en fonction des principes des 3R, lesquels se refl\u00e8tent dans la l\u00e9gislation suisse et les normes internationales. Il est obligatoire d\u2019en tenir compte pour tout projet. Les membres d\u2019Interpharma adh\u00e8rent \u00e0 cette strat\u00e9gie depuis plus de 10&nbsp;ans. D\u00e8s 2010, ils ont publi\u00e9 la Charte pour la protection des animaux, cr\u00e9ant ainsi la base \u00e0 la mise en \u0153uvre des 3R dans la branche pharmaceutique. Cela veut dire concr\u00e8tement: appliquer les principes de protection des animaux conform\u00e9ment aux principes des 3R <em>Reduction<\/em> (r\u00e9duction), <em>Refinement<\/em> (am\u00e9lioration) et <em>Replacement<\/em> (remplacement des \u00e9tudes sur l\u2019animal), et les promouvoir activement \u2013 en particulier pour ce qui concerne le d\u00e9veloppement et l\u2019utilisation de m\u00e9thodes et de techniques visant \u00e0 poursuivre le remplacement de l\u2019exp\u00e9rimentation animale, \u00e0 r\u00e9duire le nombre d\u2019animaux requis ou \u00e0 limiter \u00e0 un minimum les contraintes auxquelles sont soumis les animaux de laboratoire avant, pendant et apr\u00e8s l\u2019exp\u00e9rimentation.<\/p>\n\n\n\n<p>Vous trouverez le rapport complet \u00abAnimal Welfare Report 2022\u00bb sur notre site Internet www.interpharma.ch \u00e0 la rubrique Publications. Il y est disponible au format PDF en fran\u00e7ais, allemand et anglais.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La population suisse a compris l\u2019importance de la recherche impliquant des animaux pour le d\u00e9veloppement de nouveaux m\u00e9dicaments et vaccins et, en f\u00e9vrier 2022, par 79% de \u00abnon\u00bb, elle a clairement rejet\u00e9 dans les urnes l\u2019initiative d\u2019interdiction de l\u2019exp\u00e9rimentation animale et humaine. C\u2019est important car les exp\u00e9riences sur animaux restent indispensables pour \u00e9tudier des maladies [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2547,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"tags":[122],"class_list":["post-12823","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tag-communique-de-presse"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Communiqu\u00e9 de presse: Animal Welfare Report 2022: l\u2019exp\u00e9rimentation animale reste indispensable pour la recherche de nouvelles approches de traitement - Interpharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-animal-welfare-report-2022-tierversuche-sind-immer-noch-unerlaesslich-fuer-die-erforschung-neuer-behandlungsansaetze\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Communiqu\u00e9 de presse: Animal Welfare Report 2022: l\u2019exp\u00e9rimentation animale reste indispensable pour la recherche de nouvelles approches de traitement\" \/>\n<meta property=\"og:description\" content=\"La population suisse a compris l\u2019importance de la recherche impliquant des animaux pour le d\u00e9veloppement de nouveaux m\u00e9dicaments et vaccins et, en f\u00e9vrier 2022, par 79% de \u00abnon\u00bb, elle a clairement rejet\u00e9 dans les urnes l\u2019initiative d\u2019interdiction de l\u2019exp\u00e9rimentation animale et humaine. C\u2019est important car les exp\u00e9riences sur animaux restent indispensables pour \u00e9tudier des maladies [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-animal-welfare-report-2022-tierversuche-sind-immer-noch-unerlaesslich-fuer-die-erforschung-neuer-behandlungsansaetze\/\" \/>\n<meta property=\"og:site_name\" content=\"Interpharma\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-01T09:50:14+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-03T09:49:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/11\/AWR-22-Website-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"429\" \/>\n\t<meta property=\"og:image:height\" content=\"213\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"berta_admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:site\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"berta_admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-animal-welfare-report-2022-tierversuche-sind-immer-noch-unerlaesslich-fuer-die-erforschung-neuer-behandlungsansaetze\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-animal-welfare-report-2022-tierversuche-sind-immer-noch-unerlaesslich-fuer-die-erforschung-neuer-behandlungsansaetze\/\"},\"author\":{\"name\":\"berta_admin\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818\"},\"headline\":\"Communiqu\u00e9 de presse: Animal Welfare Report 2022: l\u2019exp\u00e9rimentation animale reste indispensable pour la recherche de nouvelles approches de traitement\",\"datePublished\":\"2022-11-01T09:50:14+00:00\",\"dateModified\":\"2026-03-03T09:49:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-animal-welfare-report-2022-tierversuche-sind-immer-noch-unerlaesslich-fuer-die-erforschung-neuer-behandlungsansaetze\/\"},\"wordCount\":635,\"publisher\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-animal-welfare-report-2022-tierversuche-sind-immer-noch-unerlaesslich-fuer-die-erforschung-neuer-behandlungsansaetze\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/11\/AWR-22-Website-1.jpg\",\"keywords\":[\"Communiqu\u00e9 de presse\"],\"inLanguage\":\"fr-FR\",\"copyrightYear\":\"2022\",\"copyrightHolder\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-animal-welfare-report-2022-tierversuche-sind-immer-noch-unerlaesslich-fuer-die-erforschung-neuer-behandlungsansaetze\/\",\"url\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-animal-welfare-report-2022-tierversuche-sind-immer-noch-unerlaesslich-fuer-die-erforschung-neuer-behandlungsansaetze\/\",\"name\":\"Communiqu\u00e9 de presse: Animal Welfare Report 2022: l\u2019exp\u00e9rimentation animale reste indispensable pour la recherche de nouvelles approches de traitement - Interpharma\",\"isPartOf\":{\"@id\":\"https:\/\/www.interpharma.ch\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-animal-welfare-report-2022-tierversuche-sind-immer-noch-unerlaesslich-fuer-die-erforschung-neuer-behandlungsansaetze\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-animal-welfare-report-2022-tierversuche-sind-immer-noch-unerlaesslich-fuer-die-erforschung-neuer-behandlungsansaetze\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/11\/AWR-22-Website-1.jpg\",\"datePublished\":\"2022-11-01T09:50:14+00:00\",\"dateModified\":\"2026-03-03T09:49:36+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-animal-welfare-report-2022-tierversuche-sind-immer-noch-unerlaesslich-fuer-die-erforschung-neuer-behandlungsansaetze\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-animal-welfare-report-2022-tierversuche-sind-immer-noch-unerlaesslich-fuer-die-erforschung-neuer-behandlungsansaetze\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-animal-welfare-report-2022-tierversuche-sind-immer-noch-unerlaesslich-fuer-die-erforschung-neuer-behandlungsansaetze\/#primaryimage\",\"url\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/11\/AWR-22-Website-1.jpg\",\"contentUrl\":\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/11\/AWR-22-Website-1.jpg\",\"width\":429,\"height\":213},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-animal-welfare-report-2022-tierversuche-sind-immer-noch-unerlaesslich-fuer-die-erforschung-neuer-behandlungsansaetze\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/www.interpharma.ch\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Communiqu\u00e9 de presse: Animal Welfare Report 2022: l\u2019exp\u00e9rimentation animale reste indispensable pour la recherche de nouvelles approches de traitement\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.interpharma.ch\/#website\",\"url\":\"https:\/\/www.interpharma.ch\/\",\"name\":\"Interpharma\",\"description\":\"Verband der forschenden Pharmazeutischen Firmen\",\"publisher\":{\"@id\":\"https:\/\/www.interpharma.ch\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.interpharma.ch\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.interpharma.ch\/#organization\",\"name\":\"Interpharma\",\"url\":\"https:\/\/www.interpharma.ch\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"contentUrl\":\"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"width\":\"1200\",\"height\":\"1200\",\"caption\":\"Interpharma\"},\"image\":{\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/interpharma_ch\",\"https:\/\/ch.linkedin.com\/company\/interpharma\",\"https:\/\/www.instagram.com\/interpharma_ch\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818\",\"name\":\"berta_admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"caption\":\"berta_admin\"},\"sameAs\":[\"https:\/\/interpharma.ch\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Communiqu\u00e9 de presse: Animal Welfare Report 2022: l\u2019exp\u00e9rimentation animale reste indispensable pour la recherche de nouvelles approches de traitement - Interpharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-animal-welfare-report-2022-tierversuche-sind-immer-noch-unerlaesslich-fuer-die-erforschung-neuer-behandlungsansaetze\/","og_locale":"fr_FR","og_type":"article","og_title":"Communiqu\u00e9 de presse: Animal Welfare Report 2022: l\u2019exp\u00e9rimentation animale reste indispensable pour la recherche de nouvelles approches de traitement","og_description":"La population suisse a compris l\u2019importance de la recherche impliquant des animaux pour le d\u00e9veloppement de nouveaux m\u00e9dicaments et vaccins et, en f\u00e9vrier 2022, par 79% de \u00abnon\u00bb, elle a clairement rejet\u00e9 dans les urnes l\u2019initiative d\u2019interdiction de l\u2019exp\u00e9rimentation animale et humaine. C\u2019est important car les exp\u00e9riences sur animaux restent indispensables pour \u00e9tudier des maladies [&hellip;]","og_url":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-animal-welfare-report-2022-tierversuche-sind-immer-noch-unerlaesslich-fuer-die-erforschung-neuer-behandlungsansaetze\/","og_site_name":"Interpharma","article_published_time":"2022-11-01T09:50:14+00:00","article_modified_time":"2026-03-03T09:49:36+00:00","og_image":[{"width":429,"height":213,"url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/11\/AWR-22-Website-1.jpg","type":"image\/jpeg"}],"author":"berta_admin","twitter_card":"summary_large_image","twitter_creator":"@interpharma_ch","twitter_site":"@interpharma_ch","twitter_misc":{"\u00c9crit par":"berta_admin","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-animal-welfare-report-2022-tierversuche-sind-immer-noch-unerlaesslich-fuer-die-erforschung-neuer-behandlungsansaetze\/#article","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-animal-welfare-report-2022-tierversuche-sind-immer-noch-unerlaesslich-fuer-die-erforschung-neuer-behandlungsansaetze\/"},"author":{"name":"berta_admin","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818"},"headline":"Communiqu\u00e9 de presse: Animal Welfare Report 2022: l\u2019exp\u00e9rimentation animale reste indispensable pour la recherche de nouvelles approches de traitement","datePublished":"2022-11-01T09:50:14+00:00","dateModified":"2026-03-03T09:49:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-animal-welfare-report-2022-tierversuche-sind-immer-noch-unerlaesslich-fuer-die-erforschung-neuer-behandlungsansaetze\/"},"wordCount":635,"publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"image":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-animal-welfare-report-2022-tierversuche-sind-immer-noch-unerlaesslich-fuer-die-erforschung-neuer-behandlungsansaetze\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/11\/AWR-22-Website-1.jpg","keywords":["Communiqu\u00e9 de presse"],"inLanguage":"fr-FR","copyrightYear":"2022","copyrightHolder":{"@id":"https:\/\/www.interpharma.ch\/#organization"}},{"@type":"WebPage","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-animal-welfare-report-2022-tierversuche-sind-immer-noch-unerlaesslich-fuer-die-erforschung-neuer-behandlungsansaetze\/","url":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-animal-welfare-report-2022-tierversuche-sind-immer-noch-unerlaesslich-fuer-die-erforschung-neuer-behandlungsansaetze\/","name":"Communiqu\u00e9 de presse: Animal Welfare Report 2022: l\u2019exp\u00e9rimentation animale reste indispensable pour la recherche de nouvelles approches de traitement - Interpharma","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-animal-welfare-report-2022-tierversuche-sind-immer-noch-unerlaesslich-fuer-die-erforschung-neuer-behandlungsansaetze\/#primaryimage"},"image":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-animal-welfare-report-2022-tierversuche-sind-immer-noch-unerlaesslich-fuer-die-erforschung-neuer-behandlungsansaetze\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/11\/AWR-22-Website-1.jpg","datePublished":"2022-11-01T09:50:14+00:00","dateModified":"2026-03-03T09:49:36+00:00","breadcrumb":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-animal-welfare-report-2022-tierversuche-sind-immer-noch-unerlaesslich-fuer-die-erforschung-neuer-behandlungsansaetze\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-animal-welfare-report-2022-tierversuche-sind-immer-noch-unerlaesslich-fuer-die-erforschung-neuer-behandlungsansaetze\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-animal-welfare-report-2022-tierversuche-sind-immer-noch-unerlaesslich-fuer-die-erforschung-neuer-behandlungsansaetze\/#primaryimage","url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/11\/AWR-22-Website-1.jpg","contentUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2022\/11\/AWR-22-Website-1.jpg","width":429,"height":213},{"@type":"BreadcrumbList","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/medienmitteilung-animal-welfare-report-2022-tierversuche-sind-immer-noch-unerlaesslich-fuer-die-erforschung-neuer-behandlungsansaetze\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.interpharma.ch\/fr\/"},{"@type":"ListItem","position":2,"name":"Communiqu\u00e9 de presse: Animal Welfare Report 2022: l\u2019exp\u00e9rimentation animale reste indispensable pour la recherche de nouvelles approches de traitement"}]},{"@type":"WebSite","@id":"https:\/\/www.interpharma.ch\/#website","url":"https:\/\/www.interpharma.ch\/","name":"Interpharma","description":"Verband der forschenden Pharmazeutischen Firmen","publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.interpharma.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.interpharma.ch\/#organization","name":"Interpharma","url":"https:\/\/www.interpharma.ch\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/","url":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","contentUrl":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","width":"1200","height":"1200","caption":"Interpharma"},"image":{"@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/interpharma_ch","https:\/\/ch.linkedin.com\/company\/interpharma","https:\/\/www.instagram.com\/interpharma_ch\/"]},{"@type":"Person","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818","name":"berta_admin","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","caption":"berta_admin"},"sameAs":["https:\/\/interpharma.ch"]}]}},"_links":{"self":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/12823","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/comments?post=12823"}],"version-history":[{"count":1,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/12823\/revisions"}],"predecessor-version":[{"id":12824,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/12823\/revisions\/12824"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media\/2547"}],"wp:attachment":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media?parent=12823"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/tags?post=12823"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}